Cargando…

Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome

Progressive facial hemiatrophy, also known as Parry-Romberg syndrome, is a progressive and self-limited deformation of the subcutaneous tissue volume on one side of the face that creates craniofacial asymmetry. We present the case of a patient with a five-year history of progressive right facial hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro-Govea, Yanko, De La Garza-Pineda, Oscar, Lara-Arias, Jorge, Chacón-Martínez, Hernán, Mecott-Rivera, Gabriel, Salazar-Lozano, Abel, Valdes-Flores, Everardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Plastic and Reconstructive Surgeons 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518012/
https://www.ncbi.nlm.nih.gov/pubmed/23233894
http://dx.doi.org/10.5999/aps.2012.39.6.659
_version_ 1782252507387396096
author Castro-Govea, Yanko
De La Garza-Pineda, Oscar
Lara-Arias, Jorge
Chacón-Martínez, Hernán
Mecott-Rivera, Gabriel
Salazar-Lozano, Abel
Valdes-Flores, Everardo
author_facet Castro-Govea, Yanko
De La Garza-Pineda, Oscar
Lara-Arias, Jorge
Chacón-Martínez, Hernán
Mecott-Rivera, Gabriel
Salazar-Lozano, Abel
Valdes-Flores, Everardo
author_sort Castro-Govea, Yanko
collection PubMed
description Progressive facial hemiatrophy, also known as Parry-Romberg syndrome, is a progressive and self-limited deformation of the subcutaneous tissue volume on one side of the face that creates craniofacial asymmetry. We present the case of a patient with a five-year history of progressive right facial hemiatrophy, who underwent facial volumetric restoration using cell-assisted lipotransfer (CAL), which consists of an autologous fat graft enriched with adipose-derived stem cells (ASCs) extracted from the same patient. ASCs have the capacity to differentiate into adipocytes. They also promote angiogenesis, release angiogenic growth factors, and some can survive as stem cells. The use of autologous fat as a filler in soft tissue atrophy has been satisfactory in patients with mild and moderate Parry-Romberg syndrome. Currently, CAL has showed promising results in the long term by decreasing the rate of fat reabsorption. The permanence and stability of the graft in all the injected areas has showed that autologous fat grafts enriched with stem cells could be a promising technique for the correction of defects caused by this syndrome.
format Online
Article
Text
id pubmed-3518012
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Society of Plastic and Reconstructive Surgeons
record_format MEDLINE/PubMed
spelling pubmed-35180122012-12-11 Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome Castro-Govea, Yanko De La Garza-Pineda, Oscar Lara-Arias, Jorge Chacón-Martínez, Hernán Mecott-Rivera, Gabriel Salazar-Lozano, Abel Valdes-Flores, Everardo Arch Plast Surg Case Report Progressive facial hemiatrophy, also known as Parry-Romberg syndrome, is a progressive and self-limited deformation of the subcutaneous tissue volume on one side of the face that creates craniofacial asymmetry. We present the case of a patient with a five-year history of progressive right facial hemiatrophy, who underwent facial volumetric restoration using cell-assisted lipotransfer (CAL), which consists of an autologous fat graft enriched with adipose-derived stem cells (ASCs) extracted from the same patient. ASCs have the capacity to differentiate into adipocytes. They also promote angiogenesis, release angiogenic growth factors, and some can survive as stem cells. The use of autologous fat as a filler in soft tissue atrophy has been satisfactory in patients with mild and moderate Parry-Romberg syndrome. Currently, CAL has showed promising results in the long term by decreasing the rate of fat reabsorption. The permanence and stability of the graft in all the injected areas has showed that autologous fat grafts enriched with stem cells could be a promising technique for the correction of defects caused by this syndrome. The Korean Society of Plastic and Reconstructive Surgeons 2012-11 2012-11-14 /pmc/articles/PMC3518012/ /pubmed/23233894 http://dx.doi.org/10.5999/aps.2012.39.6.659 Text en Copyright © 2012 The Korean Society of Plastic and Reconstructive Surgeons http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Castro-Govea, Yanko
De La Garza-Pineda, Oscar
Lara-Arias, Jorge
Chacón-Martínez, Hernán
Mecott-Rivera, Gabriel
Salazar-Lozano, Abel
Valdes-Flores, Everardo
Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome
title Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome
title_full Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome
title_fullStr Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome
title_full_unstemmed Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome
title_short Cell-Assisted Lipotransfer for the Treatment of Parry-Romberg Syndrome
title_sort cell-assisted lipotransfer for the treatment of parry-romberg syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518012/
https://www.ncbi.nlm.nih.gov/pubmed/23233894
http://dx.doi.org/10.5999/aps.2012.39.6.659
work_keys_str_mv AT castrogoveayanko cellassistedlipotransferforthetreatmentofparryrombergsyndrome
AT delagarzapinedaoscar cellassistedlipotransferforthetreatmentofparryrombergsyndrome
AT laraariasjorge cellassistedlipotransferforthetreatmentofparryrombergsyndrome
AT chaconmartinezhernan cellassistedlipotransferforthetreatmentofparryrombergsyndrome
AT mecottriveragabriel cellassistedlipotransferforthetreatmentofparryrombergsyndrome
AT salazarlozanoabel cellassistedlipotransferforthetreatmentofparryrombergsyndrome
AT valdesfloreseverardo cellassistedlipotransferforthetreatmentofparryrombergsyndrome